HEStaff exchange2025–2028

i-GREENPHARM · AI and machine learning assisted development of greener formulations and pharmaceutical processes based on amorphous solid dispersions

Horizon Europe — Marie Skłodowska-Curie Actions

Duration: 2025-01-01 → 2028-12-31
EU contribution: €772,800
Participants: 10
Scheme: HORIZON-TMA-MSCA-SE

Lines connect the coordinator with its partners.

Project objective

This proposal is bringing together R&I related staff by a complementary set of participating organisations that will use multidisciplinary technological approaches to provide a proof-of concept framework for designing and introducing greener practices in pharmaceuticals. Knowledge will be transferred around the core technical activity that will be the introduction of HME as a novel production method, based on AI-ML tools and supported by environmental assessment for greener pharmaceuticals.

Original text from CORDIS.

Participants

ANFARM HELLAS AP NIKOLAOU PHARMACEUTICAL INDUSTRY SA · KIFISSIACoordinatorGreece
ATLANTIC TECHNOLOGICAL UNIVERSITY · LetterkennyIreland
CHULALONGKORN UNIVERSITY · BangkokThailand
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON · ATHINAGreece
QUEEN MARY UNIVERSITY OF LONDON · LONDONUnited Kingdom
SIDROCO HOLDINGS LIMITED · NicosiaCyprus
Thailand Institute of Nuclear Technology (Public Organization) · Saimoon, Ongkarak, Nakorn NayokThailand
UNIVERSITY COLLEGE LONDON · LondonUnited Kingdom
UNIVERSITY OF LIMERICK · LimerickIreland
VODENA DOO KRAGUJEVAC · KRAGUJEVACSerbia

i-GREENPHARM · AI and machine learning assisted development of greener formulations and pharmaceutical processes based on amorphous solid dispersions

Project objective

Participants

Links